Transient Expression of Reck Under Hepatic Ischemia/Reperfusion Conditions Is Associated with Mapk Signaling Pathways

Area of Science:

• Hepatology
• Molecular Biology
• Biochemistry

Background:

• Hepatic ischemia/reperfusion (I/R) injury is a significant clinical challenge.
• Matrix metalloproteinases (MMPs) and their modulators, like RECK, play a role in tissue injury.
• Mitogen-activated protein kinase (MAPK) pathways are implicated in cellular stress responses.

Purpose of the Study:

• To investigate the role of RECK, an MMP modulator, and MAPK pathways in hepatic I/R injury.
• To analyze the temporal changes in MMPs, their inhibitors (TIMPs), and MAPKs during reperfusion.
• To correlate these molecular changes with the extent of liver damage.

Main Methods:

• Male Wistar rats underwent partial-hepatic ischemia followed by reperfusion (60 or 120 min) or sham operation.
• Liver tissues were analyzed for MMP-2, MMP-9 activity (zymography), RECK, TIMP-1, TIMP-2, MAPK activation (ERK, p38, JNK), iNOS, and eNOS expression (Western blot).
• Serum levels of AST, ALT, and alkaline phosphatase were quantified to assess liver injury.

Main Results:

• A transient decrease in hepatic RECK and TIMPs was observed, coinciding with increased MMP-2 and MMP-9 activity at 60 min reperfusion.
• Robust activation of ERK1/2, JNK1/2, and p38 MAPKs occurred at 60 min reperfusion.
• Hepatic iNOS expression peaked at 120 min reperfusion, with increased eNOS also detected at this time point. Significant, time-dependent hepatic injury was induced by I/R.

Conclusions:

• The findings suggest that a transient decrease in RECK and TIMPs, along with increased MAPK and MMP activity, are early triggering factors in reperfusion-induced hepatic injury.
• These molecular events contribute to the observed organ dysfunction following hepatic I/R.
• Understanding these mechanisms may lead to novel therapeutic strategies for mitigating liver damage.